Latest News

Introducing the new FX CorDiax dialyser

5th ed AU FX Cordiax Online

Cardioprotection – at the heart of long-term haemodialysis

The NEW FX CorDiax dialyser is designed to reduce the risks associated to cardiovascular disease in dialysis patients.

Improved survival of incident patients on HighVolume Online-HDF

AU Newsletter HighVolumeHDF icon175width

New epidemiological cohort study supports recent ESHOL data

The epidemiological cohort study compared the survival of incident patients on three different treatment modalities: high-flux hemodialysis (HD), low-volume online hemodiafiltration (OL-HDF) and HighVolume OL-HDF.1

49th ANZSN

AU Newsletter Conference Announcement ANZSN icon

Fresenius Medical Care shared recent study results on HighVolume HDF, as well as APD

This year’s ANZSN provided Fresenius Medical Care the opportunity to share the latest insights into new therapy modalities in Haemodialysis, as well as Peritoneal Dialysis.

Scientific News

5th ed AU PD vs HD Online

A new study provides insights into the cost of peritoneal dialysis versus haemodialysis across the world including Australia

While peritoneal dialysis (PD) has a number of advantages, including the possibility of it being offered in remote locations, it remains an underused modality in most parts of the world. Here we report results from a global analysis demonstrating that PD offers improved or at least similar cost-effectiveness to haemodialysis (HD) in the majority of countries.1

Latest Technology Release

5008Logo web

The new 5008 Therapy System - Beyond your expectations

The new ‘5008 Therapy System – Beyond your expectations’ provides enhanced therapy options, safety features and handling capabilities further improving management of ESRD.